The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group

Diabetologia
N G ForouhiEDEG

Abstract

The category of IFG was introduced in the late 1990s to denote a state of non-diabetic hyperglycaemia defined by a fasting plasma glucose (FPG) concentration between 6.1 and 6.9 mmol/l. In 2003 the American Diabetes Association recommended that this diagnostic threshold be lowered to 5.6 mmol/l. The justification for lowering the threshold has been questioned. This simple change in cut-off value creates a pandemic of IFG, with a two- to five-fold increase in the prevalence of IFG across the world. Such a change in threshold has far-reaching public health implications. The European Diabetes Epidemiology Group (EDEG) has reviewed the evidence for this lower cut-off point for the definition of IFG and concludes that the previous definition should not be altered. EDEG further recommends that the value of all categorical definitions of non-diabetic hyperglycaemia should be reconsidered.

References

May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·M HanefeldC Koehler
Jun 17, 2000·Diabetes Care·J E ShawK G Alberti
May 10, 2001·JAMA : the Journal of the American Medical Association·F de VegtR J Heine
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Mar 1, 2003·Diabetes Care·UNKNOWN DECODE Study Group, European Diabetes Epidemiology Group
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trial Research Group
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Nov 25, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·Q QiaoJ Tuomilehto
Nov 25, 2003·Diabetes Care·Mayer B DavidsonCharles M Alexander
Nov 25, 2004·Diabetes Care·C M M LawesUNKNOWN Asia Pacific Cohort Studies Collaboration
Mar 29, 2005·Diabetes Care·Robert RatnerUNKNOWN Diabetes Prevention Program Research Group
May 18, 2005·Annals of Internal Medicine·Alka M KanayaElizabeth Barrett-Connor
Aug 20, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·A F G CiceroA Gaddi
Oct 7, 2005·The New England Journal of Medicine·Amir TiroshUNKNOWN Israeli Diabetes Research Group
Oct 27, 2005·Diabetes Care·Chi Pang WenShu Li Wang

❮ Previous
Next ❯

Citations

Feb 19, 2009·Diabetologia·E FerranniniC Gonzales-Villalpando
Dec 28, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·A-M Guedj
Jul 8, 2010·Internal Medicine·Tadashi MoriuchiJunji Koizumi
May 28, 2009·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Takashi Kadowaki
Dec 16, 2011·The American Journal of Clinical Nutrition·Cindy W LeungEric L Ding
Jul 6, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·E HagmanR W Holl
Sep 12, 2014·Diabetologia·Yi HuangYuli Huang
May 28, 2011·Acta Diabetologica·Mohammadreza BozorgmaneshFereidoun Azizi
May 16, 2014·Canadian Journal of Diabetes·Ronald GoldenbergZubin Punthakee
Mar 19, 2013·Journal of Psychosomatic Research·Karoline LukaschekUNKNOWN KORA Investigators
Feb 2, 2011·The Medical Clinics of North America·Stephen Colagiuri
Dec 18, 2010·Diabetes & Metabolism·A-M Guedj
Mar 1, 2009·Revista de psiquiatrí́a y salud mental·Marc De HertHans-Jürgen Möller
Jul 29, 2008·Diabetes Research and Clinical Practice·Stephen ColagiuriNicholas J Wareham
Apr 9, 2008·European Journal of Internal Medicine·Sergio Martinez-HervasJuan F Ascaso
Oct 31, 2007·Journal of Diabetes and Its Complications·George N IoannouEdward J Boyko
Nov 26, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·K InoueK Akimoto
Jan 30, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·N G ForouhiN J Wareham
Oct 9, 2007·Diabetes/metabolism Research and Reviews·Giorgio SestiUNKNOWN Group of Italian Scientists of Insulin Resistance (GISIR)
Feb 22, 2007·Diabetes/metabolism Research and Reviews·Francesco AndreozziGiorgio Sesti
Dec 14, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·K InoueK Akimoto
Aug 7, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·W N SchoeningP Neuhaus
Dec 17, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·W RathmannC Meisinger
Jun 12, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·C MeisingerW Rathmann
Jun 12, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·M B SchulzeH G Joost
Jan 8, 2013·General and Comparative Endocrinology·Aleksandra BartelikAlicja Józkowicz
Mar 5, 2015·Atencion primaria·M Mata-CasesUNKNOWN Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes
Mar 11, 2015·Semergen·M Mata-CasesUNKNOWN Consensus Working Group and Clinical Guidelines of the Spanish Society of Diabetes
Feb 5, 2015·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·M Mata-CasesUNKNOWN en nombre del Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes
Jan 3, 2015·Revista clínica española·M Mata-CasesUNKNOWN en nombre del Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes
Jul 9, 2011·Diabetes & Metabolism Journal·Sang Youl Rhee, Jeong-Taek Woo
May 28, 2011·Diabetes Care·David B SacksUNKNOWN Evidence-Based Laboratory Medicine Committee of the American Association for Clinical Chemistry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetes Care
Saul GenuthExpert Committee on the Diagnosis and Classification of Diabetes Mellitus
Diabetes Care
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The New England Journal of Medicine
Jaakko TuomilehtoFinnish Diabetes Prevention Study Group
The New England Journal of Medicine
W C KnowlerDiabetes Prevention Program Research Group
© 2021 Meta ULC. All rights reserved